Dr. Wayne Brisbane specializes in prostate cancer diagnosis and treatment. He is involved in multiple clinical trials, including new treatment energies for prostate cancer focal therapy: ‘NanoKnife’ (Irreversible electroporation), HIFU (High Intensity Focused Ultrasound), and Cryoablation. These treatment options are only offered by a handful of urology programs around the country.
Areas of Expertise (15)
Transperineal Prostate Biopsy
Focal Laser Ablation
PSMA PET CT
Retzius Sparing Prostatectomy
High Intensity Focused Ultrasound
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional SamplingEuropean Urology
Wayne G. Brisbane, et al.
Systematic prostate biopsies add to the cancer detection rate of targeted biopsies, but the explanation for that increased sensitivity is not yet clear.
The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomyUrology Oncology
Andrew T. Lenis, et al.
To investigate treatment patterns of partial cystectomy (PC), neoadjuvant chemotherapy (NAC), lymph node dissection (LND), and treatment delays, and the associations with overall survival (OS) among patients with muscle-invasive bladder cancer.
Relationship Between Mobile Digital Sensor Monitoring and Perioperative Outcomes: Systematic ReviewJMIR Perioperative Medicine
Ali Memon, et al.
Monitoring surgical recovery has traditionally been confined to metrics measurable within the hospital and clinic setting. However, commercially available mobile sensors are now capable of extending measurements into a patient's home. As these sensors were developed for nonmedical applications, their clinical role has yet to be established. The aim of this systematic review is to evaluate the relationship between data generated by mobile sensors and postoperative outcomes.